O'Brien P Q, Fischer A B, Anderson J P. "一种的合成方法" [P]. US Patent, US 11374538 B2, 2022-06-22.
Chen K W, Klinger H, Park J H. "Method for the Synthesis of N-Methyl-N-((5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-3-yl)methyl)propan-2-amine" [P]. US Patent, US 9620732 B2, 2016-07-13.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 687, (10), 7371-7389.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2023, 1076, 9845-9861.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of N-Methyl-N-((5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-3-yl)methyl)propan-2-amine Using HRMS and NMR". Talanta, 2012, 2293, 8806-8822.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2011, 211, (4), 5325-5341.